Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen Research & Development, LLC
XBiotech owned bermekimab and sponsored and completed study prior to Dec 30, 2019.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Age: ≥18
2. History of pyoderma gangrenosum with or without other systemic disease.
You may not be if
1. Treatment with any biologicals (including intravenous immunoglobulin) or investigational agents within the last 4 weeks (or 5 half-lives, whichever is longer).
2. Treatment with corticosteroids or cyclosporine within the last 2 weeks.
